← SynDRA
ORTERONEL
SynDRA canonical compound SYN0028398 — structure-anchored drug synonym record
Clinical phase
Phase 3
Primary target(s)
CYP17A1
Mechanism of action
androgen biosynthesis inhibitor | androgen receptor antagonist | cytochrome P450 inhibitor
All known targets
CYP17A1
Mechanisms of action (all sources)
CYP17A1 INHIBITOR
Cytochrome P450 17A1 inhibitor
androgen biosynthesis inhibitor
AR ANTAGONIST
cytochrome P450 inhibitor
CYP17A1 MODULATOR
Cross-references
PubChem CID:
9883029
ChEMBL:
CHEMBL1921976
DrugBank:
DB12066
ChEBI:
94965
KEGG:
D10146
PDB:
7D6
Wikipedia:
Orteronel
TTD: D0X3OI
Synonyms
TAK-700
TAK 700
orteronelum
UE5K2FNS92
RefChem:856930
DTXCID101748551
CYP17A1 Lyase Inhibitor TAK-700
Androgen Synthesis Inhibitor TAK-700
(S)-Orteronel
TAK700
TAK-700 (S-form)
Orteronel [INN]
Orteronel [USAN:INN]
UNII-UE5K2FNS92
(+)-orteronel
MFCD20528078
ORTERONEL [JAN]
Orteronel (JAN/USAN)
ORTERONEL [USAN]
ORTERONEL [WHO-DD]
orb1689515
SCHEMBL6126076
SCHEMBL29363567
GTPL13853
S-TAK-700
EX-A159
CHEBI:231353
(S)-TAK700
csa:566939-85-3;Orteronel
GLXC-06640
HMS3750I13
RXA93985
Orteronel,CAS:566939-85-3
BDBM50358201
CYP17A1 Inhibitor II, TAK-700
AKOS030526849
CS-0580
SB16686
NCGC00378767-02
Look up ORTERONEL in the interactive SynDRA portal →